NO139408C - Analogifremgangsmaate til fremstilling av amfetaminderivater med anti-drepessiv og anxiolytisk effekt - Google Patents
Analogifremgangsmaate til fremstilling av amfetaminderivater med anti-drepessiv og anxiolytisk effektInfo
- Publication number
- NO139408C NO139408C NO743177A NO743177A NO139408C NO 139408 C NO139408 C NO 139408C NO 743177 A NO743177 A NO 743177A NO 743177 A NO743177 A NO 743177A NO 139408 C NO139408 C NO 139408C
- Authority
- NO
- Norway
- Prior art keywords
- ampetamine
- killing
- derivatives
- preparation
- anxiolytic effect
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Quinoline Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO751160A NO140889C (no) | 1973-09-04 | 1975-04-04 | Forbindelser for anvendelse som mellomprodukter for fremstilling av terapeutisk virksomme 3-aminoamfetaminderivater |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE7312001A SE382047B (sv) | 1973-09-04 | 1973-09-04 | Forfarande for framstellning av 4-aminoamfetaminderivat |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO743177L NO743177L (no) | 1975-04-01 |
| NO139408B NO139408B (no) | 1978-11-27 |
| NO139408C true NO139408C (no) | 1979-03-07 |
Family
ID=20318423
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO743177A NO139408C (no) | 1973-09-04 | 1974-09-04 | Analogifremgangsmaate til fremstilling av amfetaminderivater med anti-drepessiv og anxiolytisk effekt |
| NO791507A NO142624C (no) | 1973-09-04 | 1979-05-04 | Forbindelser for anvendelse som mellomprodukter for fremstilling av terapeutisk virksomme 4-aminoamfetaminderivater |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO791507A NO142624C (no) | 1973-09-04 | 1979-05-04 | Forbindelser for anvendelse som mellomprodukter for fremstilling av terapeutisk virksomme 4-aminoamfetaminderivater |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US3996381A (no) |
| JP (1) | JPS5835177B2 (no) |
| AT (1) | AT336566B (no) |
| BE (1) | BE819515A (no) |
| CA (1) | CA1051436A (no) |
| CH (2) | CH603547A5 (no) |
| DE (1) | DE2440734C2 (no) |
| DK (1) | DK139716B (no) |
| FI (1) | FI62281C (no) |
| FR (1) | FR2242079B1 (no) |
| GB (1) | GB1461667A (no) |
| HK (1) | HK75778A (no) |
| IE (1) | IE40514B1 (no) |
| LU (1) | LU70852A1 (no) |
| NL (1) | NL7411753A (no) |
| NO (2) | NO139408C (no) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030119884A1 (en) * | 2000-11-01 | 2003-06-26 | Epstein Mel H. | Methods and compositions for regulating memory consolidation |
| US6828351B2 (en) * | 2000-11-01 | 2004-12-07 | Sention, Inc. | Methods and compositions for regulating memory consolidation |
| US7619005B2 (en) * | 2000-11-01 | 2009-11-17 | Cognition Pharmaceuticals Llc | Methods for treating cognitive impairment in humans with Multiple Sclerosis |
| US20050059743A1 (en) * | 2000-11-01 | 2005-03-17 | Sention, Inc. | Methods for treating mild cognitive impairment and alzheimer's disease |
| US20030232890A1 (en) * | 2000-11-01 | 2003-12-18 | Sention, Inc. | Methods for treating an impairment in memory consolidation |
| US20070117869A1 (en) * | 2000-11-01 | 2007-05-24 | Cognition Pharmaceuticals Llc | Methods for treating coginitive impairment and improving cognition |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3117160A (en) * | 1961-07-27 | 1964-01-07 | Pfizer & Co C | Aralkylamines |
| US3496195A (en) * | 1966-05-11 | 1970-02-17 | Chinoin Gyogyszer Es Vegyeszet | D-o-bromo-phenyl-isopropyl-methylpropinylamine and its salts |
-
1974
- 1974-08-14 US US05/497,295 patent/US3996381A/en not_active Expired - Lifetime
- 1974-08-24 DE DE2440734A patent/DE2440734C2/de not_active Expired
- 1974-08-30 AT AT702574A patent/AT336566B/de not_active IP Right Cessation
- 1974-09-03 CA CA208,356A patent/CA1051436A/en not_active Expired
- 1974-09-03 GB GB3849974A patent/GB1461667A/en not_active Expired
- 1974-09-03 IE IE1824/74A patent/IE40514B1/xx unknown
- 1974-09-03 JP JP49100618A patent/JPS5835177B2/ja not_active Expired
- 1974-09-03 FI FI2576/74A patent/FI62281C/fi active
- 1974-09-03 CH CH1173577A patent/CH603547A5/xx not_active IP Right Cessation
- 1974-09-03 FR FR7429970A patent/FR2242079B1/fr not_active Expired
- 1974-09-03 DK DK464774AA patent/DK139716B/da not_active IP Right Cessation
- 1974-09-03 CH CH1195874A patent/CH599106A5/xx not_active IP Right Cessation
- 1974-09-04 NO NO743177A patent/NO139408C/no unknown
- 1974-09-04 BE BE148180A patent/BE819515A/xx not_active IP Right Cessation
- 1974-09-04 LU LU70852A patent/LU70852A1/xx unknown
- 1974-09-04 NL NL7411753A patent/NL7411753A/xx not_active Application Discontinuation
-
1978
- 1978-12-28 HK HK757/78A patent/HK75778A/xx unknown
-
1979
- 1979-05-04 NO NO791507A patent/NO142624C/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO139408B (no) | 1978-11-27 |
| NO791507L (no) | 1975-03-05 |
| JPS5835177B2 (ja) | 1983-08-01 |
| FI62281C (fi) | 1982-12-10 |
| DK139716C (no) | 1979-09-17 |
| DE2440734A1 (de) | 1975-03-13 |
| ATA702574A (de) | 1976-09-15 |
| FI257674A (no) | 1975-03-05 |
| DK139716B (da) | 1979-04-02 |
| FR2242079B1 (no) | 1978-07-21 |
| NL7411753A (nl) | 1975-03-06 |
| HK75778A (en) | 1979-01-05 |
| US3996381A (en) | 1976-12-07 |
| NO142624C (no) | 1980-09-17 |
| AT336566B (de) | 1977-05-10 |
| IE40514L (en) | 1975-03-04 |
| CH603547A5 (no) | 1978-08-31 |
| BE819515A (fr) | 1975-03-04 |
| FI62281B (fi) | 1982-08-31 |
| NO743177L (no) | 1975-04-01 |
| GB1461667A (en) | 1977-01-19 |
| JPS5050329A (no) | 1975-05-06 |
| DK464774A (no) | 1975-05-05 |
| NO142624B (no) | 1980-06-09 |
| IE40514B1 (en) | 1979-06-20 |
| AU7283374A (en) | 1976-03-04 |
| CA1051436A (en) | 1979-03-27 |
| LU70852A1 (no) | 1975-06-11 |
| DE2440734C2 (de) | 1985-01-24 |
| FR2242079A1 (no) | 1975-03-28 |
| CH599106A5 (no) | 1978-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE393800B (sv) | Forfarande for framstellning av bensoylamino-alkyl-fenoxi-alkylkarbonsyraderivat med lipidsenkande effekt | |
| NO139560C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater | |
| SE393381B (sv) | Analogiforfarande for framstellning av 8-azapurin - 6 - onderivat | |
| NO138374C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme 4-fenoksyfenoksyalkankarboksylsyrederivater | |
| SE390304B (sv) | Analogiforfarande for framstellning av 4-hydroxi-5-etyl-6-fonylpyrimidin | |
| DK131867C (da) | Analogifremgangsmade til fremstilling af adenosinderivater | |
| NO141689C (no) | Fremgangsmaate for fremstilling av aminosyrene d-(-)-alanin og d-(-)-valin. | |
| SE403106B (sv) | Forfarande vid framstellning av 14-hydroximorfinanderivat | |
| DK137273C (da) | Analogifremgangsmaade til fremstilling af phenylalkanolderivater | |
| NO137387C (no) | Analogifremgangsm}te til fremstilling av 5-metyltiopyrimidiner med terapeutisk virkning | |
| SE7712151L (sv) | Forfarande for framstellning av linkomycinderivat | |
| NO139408C (no) | Analogifremgangsmaate til fremstilling av amfetaminderivater med anti-drepessiv og anxiolytisk effekt | |
| SE402456B (sv) | Analogiforfarande for framstellning av fenyletylaminderivat med anorexigen aktivitet | |
| SE399069B (sv) | Analogiforfarande for framstellning av triazolo-pyridino-isokinolin-derivat | |
| NO137752C (no) | Analogifremgangsmaater til fremstilling av forbindelser med antiarrytmisk virkning | |
| FI54672B (fi) | Foerfarande foer framstaellning av livsmedel med groenmoegelarom | |
| NO139125C (no) | Analogifremgangsmaate for fremstilling av cykloheksantetrolderivater | |
| SE410732B (sv) | Analogiforfarande for framstellning av anilidderivat med terapeutisk verkan | |
| SE7613500L (sv) | Forfarande for framstellning av cefemderivat | |
| NO140062C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminoderivater av pyrazolopyridin-ketoner | |
| SE415659B (sv) | Forfarande for framstellning av basiskt substituerade xanten- och tioxantenderivat | |
| SE408177B (sv) | Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat | |
| SE409206B (sv) | Forfarande for framstellning av kinoxalindionderivat med hypnotisk verkan | |
| DK136249B (da) | Analogifremgangsmade til fremstilling af xanthenderivater | |
| SE409455B (sv) | Analogiforfarande for framstellning av nitroimidazolyl-kinazolinderivat |